Shanghai Pharmaceuticals Holding Co., Ltd
SHPMY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $45,060 | $38,541 | $39,010 | $34,301 |
| - Cash | $35,744 | $30,518 | $27,401 | $22,390 |
| + Debt | $47,792 | $42,897 | $38,561 | $31,689 |
| Enterprise Value | $57,108 | $50,920 | $50,170 | $43,599 |
| Revenue | $275,251 | $260,295 | $231,981 | $215,824 |
| % Growth | 5.7% | 12.2% | 7.5% | – |
| Gross Profit | $30,632 | $31,328 | $30,486 | $28,543 |
| % Margin | 11.1% | 12% | 13.1% | 13.2% |
| EBITDA | $12,065 | $10,905 | $12,421 | $11,275 |
| % Margin | 4.4% | 4.2% | 5.4% | 5.2% |
| Net Income | $4,553 | $3,768 | $5,617 | $5,093 |
| % Margin | 1.7% | 1.4% | 2.4% | 2.4% |
| EPS Diluted | 6.15 | 5.1 | 8.05 | 8.95 |
| % Growth | 20.6% | -36.6% | -10.1% | – |
| Operating Cash Flow | $5,827 | $5,232 | $4,743 | $5,061 |
| Capital Expenditures | -$2,401 | -$2,971 | -$2,685 | -$4,119 |
| Free Cash Flow | $3,426 | $2,261 | $2,058 | $943 |